In the original article, there was an error in affiliation 3. The corrected affiliation is “Key Laboratory of Digital Technology in Medical Diagnostics of Zhejiang Province, Hangzhou, China.”
In addition, the percentage of KIT mutations in GISTs was calculated incorrectly.
A correction has been made to Abstract, Results, sentence 2. The new sentence reads as follows:
“KIT mutations occurred most often in GISTs (94/106, 88.68%), followed by point mutations in PDGFRA.”
A correction has been made to Results, Gene Mutation Distributions and Frequencies, sentence 2. The new sentence reads as follows:
“KIT mutations occurred most often in GISTs (94 of 106 tumors, 88.68%), followed by the point mutation in PDGFRA.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
gastrointestinal stromal tumors, molecular subtypes, clinicopathological features, next-generation sequencing, target therapy
Citation
Qian H, Yan N, Hu X, Jiang J, Cao Z and Shen D (2022) Corrigendum: Molecular Portrait of GIST Associated With Clinicopathological Features: A Retrospective Study With Molecular Analysis by a Custom 9-Gene Targeted Next-Generation Sequencing Panel. Front. Genet. 13:945357. doi: 10.3389/fgene.2022.945357
Received
16 May 2022
Accepted
01 June 2022
Published
28 June 2022
Volume
13 - 2022
Edited and reviewed by
Michael Baudis, University of Zurich, Switzerland
Updates
Copyright
© 2022 Qian, Yan, Hu, Jiang, Cao and Shen.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Dan Shen, shendan@dazd.cn
† These authors have contributed equally to this work
This article was submitted to Cancer Genetics and Oncogenomics, a section of the journal Frontiers in Genetics
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.